{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:35Z","timestamp":1790959295734,"version":"4.1.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2011,11,30]]},"DOI":"10.2217\/fon.11.107","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T15:02:06Z","timestamp":1320159726000},"page":"1247-1253","source":"Crossref","is-referenced-by-count":30,"title":["Axitinib in the Treatment of Metastatic Renal Cell Carcinoma"],"prefix":"10.1080","volume":"7","author":[{"given":"Thai H","family":"Ho","sequence":"first","affiliation":[{"name":"Department of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jonasch","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Oncology, MD Anderson Cancer Center, Houston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,11]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20121"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.192"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1065-y"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-010-9511-6"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0652"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.143"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70285-1"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.7034"},{"key":"e_1_3_2_3_9_1","unstructured":"Rini BI EscudierB TomczakPet al. Axitinib versus sorafenib as second-line therapy for metastatic renal cell carcinoma (mRCC): results of Phase III AXIS trial. Presented at: 47th ASCO Annual Meeting (2011). Chicago IL USA 4\u20138 June 2011."},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.09.015"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.0108"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0717"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61039-9"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1693"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601909359929"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.10.016"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09639"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08672"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-02-2832"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1443"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm800566m"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609329103"},{"key":"e_1_3_2_3_23_1","unstructured":"Jonasch E BairA Chen Y RiniBI. Axitinib with or without dose titration as first-line therapy for metastatic renal cell carcinoma (mRCC).Presented at:46th ASCO Annual Meeting (2010).Chicago IL USA 4\u20138 June 2010."},{"key":"e_1_3_2_4_2_1","unstructured":"NIH clinical trial: axitinib (AG-013736) for the treatment of metastatic renal cell cancer http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00920816?term=axitinib&rank=5"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.11.107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:43:42Z","timestamp":1719125022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.11.107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11,30]]}},"alternative-id":["10.2217\/fon.11.107"],"URL":"https:\/\/doi.org\/10.2217\/fon.11.107","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}